Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NQ:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
5 Biotechnology Stocks to Buy Now
September 29, 2015
Tags
NASDAQ:IDIX
Stocks to Buy
NASDAQ:INCY
From
InvestorPlace
6 Biotechnology Stocks to Buy Now
September 22, 2015
Tags
NASDAQ:CLDN
NASDAQ:LJPC
NASDAQ:PGNX
From
InvestorPlace
6 Biotechnology Stocks to Buy Now
September 15, 2015
Tags
NASDAQ:PGNX
NASDAQ:LJPC
NASDAQ:CLDN
From
InvestorPlace
6 Biotechnology Stocks to Buy Now
September 08, 2015
Tags
NASDAQ:IDIX
NASDAQ:INCY
Stocks to Buy
From
InvestorPlace
Armetheon Raises $24.3 Million From Taiwan/China Investors
February 06, 2015
Armetheon, a San Francisco area specialty biopharma, raised $24.3 million in a Series B funding that will be used to underwrite a Phase III trial of its oral anticoagulant, tecarfarin. Participants in...
From
ChinaBio® Today
What Investors Are Watching For In Regulus Therapeutics' Next Data Release
January 30, 2015
Biotech companies that treat Hepatitis C were on fire in 2014. The leader of the pack, Gilead Sciences, Inc. (NASDAQ: GILD), had the ...
Tags
RGLS
GILD
ENTA
From
Benzinga
Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)
August 27, 2014
The biotechnology industry had a big day Monday after the news of Swiss pharmaceutical giant Roche agreed to acquire the U.S biotech ...
Tags
MRK
GILD
AMGN
From
Benzinga
UPDATE: Deutsche Bank Initiates Coverage On Merck
August 27, 2014
Deutsche Bank initiated coverage of Merck (NYSE: MRK) with a Hold rating and price target of $63. Analyst Gregg Gilbert outlined ...
Tags
Analyst Ratings
General
Initiation
From
Benzinga
There's still hunger for 'blockbuster' biotech deals
August 25, 2014
Roche's $8.3 billion deal for InterMune is one of the few this year that returns to the traditional model of big pharma buying smaller biotech.
Tags
Health Care IT
Pfizer Inc
InterMune Inc
From
CNBC.com News
Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis
August 07, 2014
Editor Note: For more information about this release, please scroll to bottom
From
PR Newswire
Ukraine Tension Prominent As Dow Suffers Triple Point Digit Loss; S&P 500 & Nasdaq Also Lower
August 05, 2014
U.S. stocks declined and erased Monday's gains following reports that Russian troops were lining on the borders of Ukraine ...
Tags
Coach
CHA
BTU
From
Benzinga
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
August 05, 2014
From
Business Wire News Releases
Merck Completes Tender Offer to Acquire Idenix
August 04, 2014
From
Business Wire News Releases
Idenix Pharmaceuticals Reports Second Quarter and Six Month 2014 Financial Results
July 31, 2014
From
GlobeNewswire News Releases
Merck (MRK) Shares Rise, Pfizer (PFE) Stock Slumps on Mixed Earnings By Jim Bach
July 29, 2014
Two American pharmaceutical giants reported earnings this morning, both showing flagging sales - but one ended the day with a gain. The post Merck (MRK) Shares Rise, Pfizer (PFE) Stock Slumps on Mixed...
Tags
PFE shares
Market Update
MRK shares
From
Money Morning
Hottest Healthcare Stocks Now – SHPG ISRG AGN IDIX
July 17, 2014
Tags
Hot Stocks
NASDAQ:IDIX
NYSE:LCI
From
InvestorPlace
Biotechnology Stocks Technical Review -- Research on Medivation, Idenix Pharma, Nanosphere, and Progenics Pharma
July 11, 2014
Editor Note: For more information about this release, please scroll to bottom.
From
PR Newswire
Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline
July 03, 2014
The hepatitis C industry has been on fire since Merck (NYSE: MRK) paid a 230 percent premium for pharmaceutical company Idenix (NASDAQ: ...
Tags
Health Care
IDIX
ACHN
From
Benzinga
Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly
June 27, 2014
Merck (NYSE: MRK) paid a 230 percent premium for Hepatitis C-focused Idenix Pharmaceuticals (NASDAQ: IDIX). News of the massive ...
Tags
MRK
ENTA
Interview
From
Benzinga
Idenix Pharmaceuticals Stock Sees Short Interest Fall 16%
June 25, 2014
The most recent short interest data has been released by the NASDAQ for the 06/13/2014 settlement date, which shows a 3,181,609 share decrease in total short interest for Idenix Pharmaceuticals Inc...
Tags
Stocks
From
Market News Video
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Investor Alert: Lawsuit Filed to Halt the Takeover by Merck
June 24, 2014
San Diego, CA -- (SBWIRE) -- 06/24/2014 -- An investor, who currently holds shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) filed a lawsuit in effort to halt the takeover of Idenix Pharmaceuticals...
From
SBWire - Latest Press Releases
Market Wrap For June 20: Yet Again, Dow And S&P 500 Indices Hit New Highs
June 20, 2014
U.S. stocks were slightly higher as the Dow and S&P 500 indices continue hitting new all-time highs following positive comments ...
Tags
AbbVie
COH
Carmax
From
Benzinga
Baird Comments On Achillion's Bullish Share Action
June 20, 2014
Baird analyst Brian Skorney reported on “increasingly bullish” share action of Achillion Pharmaceuticals (NASDAQ: ACHN) ...
Tags
Brian Skorney
Analyst Color
Price Target
From
Benzinga
Merck Begins Tender Offer to Acquire Idenix
June 20, 2014
From
Business Wire News Releases
This Is The Best Way to Profit from the Biotech Stocks Rebound By Michael A. Robinson
June 19, 2014
Late last month, I told you that biotech is one of the best ways to profit from the tech rebound. Somewhat ironically, a rollover in biotech stocks was one of the proximate causes of the overall...
Tags
Biotechs
Gilead stock
GILD stock
From
Money Morning
Noteworthy ETF Inflows: XBI, IDIX, ACHN, MNKD
June 19, 2014
Symbols mentioned in this story: XBI, IDIX, ACHN, MNKD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors
June 17, 2014
From
Business Wire News Releases
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Idenix Pharmaceuticals, Inc. In Connection With The Proposed Sale Of The Company To Merck & Co., Inc.
June 16, 2014
From
Business Wire News Releases
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Investor Alert: Investigation of Buyout by Merck
June 16, 2014
San Diego, CA -- (SBWIRE) -- 06/16/2014 -- An investigation on behalf of investors, who currently hold shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX), was announced concerning whether the takeover...
From
SBWire - Latest Press Releases
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Idenix Pharmaceuticals, Inc. in Connection With The Sale of The Company - IDIX
June 13, 2014
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.